Germany’s Merck KGaA is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical ...

(Corrects third to last paragraph to say "the erosion from LOEs (loss of exclusivity)", not "from LOEs (levels of evidence)") ...

The company is reportedly seen as an attractive acquisition target due to its diversified operations across two segments.

The partnership will be a joint venture (JV) which the German pharma company will manage through its new Bayer LifeScience Centre (BLSC) unit, combining the 'molecular scissors' gene-editing ...

An employee shows processed flowers of cannabis (marijuana) at the production site of German ... [+] pharmaceutical company Demecan for medical cannabis in Ebersbach near Dresden, eastern Germany ...

SpringWorks Therapeutics stock surged over Monday after a report from Reuters that German medical tech giant Merck KGaA could be close to acquiring the company.

The decision to cancel trips by auditors has been supported by the German pharmaceutical industry. "They go into the companies and look around, they take notes, they collect data and they are ...

Fennec Pharma’s partner Norgine Pharma launches Pedmarqsi in Germany: Monday, February 10, 2025, 14:00 Hrs [IST] Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, ...

PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin ...

the German pharma and technology company said on Thursday. Merck raises outlook for electronics and healthcare, sees improved chip market demand Germany's Merck on Friday raised its forecast for ...

X-Elio will supply 245GWh of clean energy annually to four pharmaceutical companies through its Lorca Solar project.